
CVS HEALTH Corp company profile
$89.35−0.49%Close 13 Nov 2026 · Market value $113.1B
About CVS HEALTH Corp
CVS Health Corporation is an American multinational healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000. CVS started in Lowell, Massachusetts by brothers Stanley and Sidney Goldstein and their partner Ralph Hoagland. The name stood for Consumer Value Stores.
On November 4, 2026, CVS announced that they will split into two companies, making it the largest split in the healthcare business.
From Wikipedia, shared under CC BY-SA.
Company facts
| Ticker | CVS · NYSE |
|---|
| Sector | Retail |
|---|
| Industry | Health Care Services |
|---|
| Index | S&P 500 |
|---|
| Fiscal year ends | 31 December |
|---|
| Reporting currency | USD |
|---|
| CIK | 64803 |
|---|
Officers and directors
| Name | Role | Shares owned | Latest Form 4 |
|---|
| Larry M. Robbins | Director | 8.6M · < 1% | Open-market sale, 21 May 2026 |
|---|
| J. David Joyner | President, CEO and Chair · Director | 615K · < 1% | Shares withheld for tax, 1 Apr 2026 |
|---|
| Prem S. Shah | EVP and Group President | 590K · < 1% | Shares withheld for tax, 1 Apr 2026 |
|---|
| C. David Brown II | Director | 213K · < 1% | Grant or award, 14 May 2026 |
|---|
| Tilak Mandadi | EVP, Chief Exp & Tech Officer | 211K · < 1% | Open-market sale, 8 May 2026 |
|---|
| Thomas F. Cowhey | EVP and CFO | 106K | Shares withheld for tax, 1 Apr 2025 |
|---|
| Steven H. Nelson | EVP and President, Aetna | 69.4K | Shares withheld for tax, 1 Apr 2026 |
|---|
| Roger N. Farah | Director | 57.7K · < 1% | Shares withheld for tax, 30 Nov 2025 |
|---|
| Michael F. Mahoney | Director | 50.6K · < 1% | Grant or award, 15 May 2025 |
|---|
| Fernando Aguirre | Director | 41.6K · < 1% | Disposition to the issuer, 21 May 2026 |
|---|
| Anne M. Finucane | Director | 39.4K · < 1% | Grant or award, 20 Nov 2025 |
|---|
| Jeffrey R. Balser, M.D., Ph.D. | Director | 13.7K · < 1% | Grant or award, 14 May 2026 |
|---|
| Guy P. Sansone | Director | 13.7K · < 1% | Grant or award, 14 May 2026 |
|---|
| J. Scott Kirby | Director | 13.0K · < 1% | Grant or award, 14 May 2026 |
|---|
| Leslie V. Norwalk | Director | 5.9K · < 1% | Grant or award, 14 May 2026 |
|---|
| Douglas H. Shulman | Director | 5.9K · < 1% | Grant or award, 20 Nov 2025 |
|---|
| Brian O. Newman | EVP, Chief Financial Officer | 51 · < 1% | Shares withheld for tax, 31 May 2026 |
|---|
| John E. Gallina | Director | 0 | Grant or award, 19 Mar 2026 |
|---|
| Clark James David | SVP, Cont & Chief Acct Officer | — | Shares withheld for tax, 26 Jun 2026 |
|---|
| Compton-Phillips Amy | EVP, Chief Medical Officer | — | Shares withheld for tax, 31 May 2026 |
|---|
Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.
CVS in the terminal
The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.